Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients

NCT06672692 is registered in ClinicalTrials.gov with DiaSorin Molecular LLC as lead sponsor.

NCT NCT06672692
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06672692 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Site Clinical Evaluation of the LIAISON NES FLU A/B, RSV & COVID-19 Assay in Symptomatic Patients
Lead sponsor
DiaSorin Molecular LLC
Phase
Not applicable
Overall status
Recruiting
Start date
September 30, 2024
Completion date
May 31, 2025
Enrollment
1,000 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid 19, influenza a, influenza b, rsv